<DOC>
	<DOCNO>NCT02723110</DOCNO>
	<brief_summary>Recent genetic association study identify variant Peptidyl-Glycine alpha-amidating mono-oxygenase ( PAM ) gene increase risk diabetes likely defect beta-cell function . This follow support novel kinetic assay cellular study . This investigation recall heterozygous carrier risk allele rs78408340 age , BMI gender match control Oxford Biobank . The study compare incretin effect , glucagon-like peptide-1 ( GLP-1 ) , insulin , glucose level PAM protein activity individual without risk variant . The aim study gain mechanistic insight effect variant human physiology diabetes pathogenesis .</brief_summary>
	<brief_title>Defining Physiological Mechanisms Risk Genes Hyperglycaemia , Insulin Resistance Type 2 Diabetes</brief_title>
	<detailed_description>Note : The study utilize adaptive study design interim analysis 40 volunteer ( 20 v 20 ) possibility add additional 20 volunteer study ( 10 v 10 ) criterion futility clear effect meet . The criterion ; stop reject null hypothesis &gt; 2.490 stop accept null hypothesis &lt; 1.033 . If fall value additional 20 volunteer ( 10 v10 ) recruit . The decision stop additional volunteer base incretin effect ( primary outcome ) .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Adult , age 3065 inclusive , healthy , appropriate genotype Mental capacity consent Demographics : &lt; 30 &gt; 65 year old Medical history : Bariatric surgery , surgery gut/ stomach ; history recent significant weight loss ( &gt; 10 % weight last year ) ; know cardiovascular disease Medications : Currently prescribed glucoselowering medication , oral/IV corticosteroid treatment , medication effect gastric motility glucose metabolism</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Type 2 Diabetes Risk</keyword>
</DOC>